evidoria

← Back to browse

Good practice Imported

Malta Life Sciences Park

Malta · San Ġwann · See the Malta profile

Evidence: Descriptive / self-reported Top 97% 38/100 · Ask Evidence Copilot about this practice

Malta's national life-sciences park, run by agency Malta Enterprise, links the University of Malta, Mater Dei Hospital and the Oncology Hospital with 13,500 m² of labs and offices; it targeted 500+ jobs by 2019, though achievement is unconfirmed.

13,500 m²
Lab/office space
61
Lab units
11
Dedicated incubation units
500+ jobs
Job-creation target (by 2019)
Malta Life Sciences Park

Details

Maturity
Established
Promoter
Malta Enterprise, with the University of Malta, Mater Dei Hospital and Malta's Oncology Hospital
Period
2016–present
Region (NUTS)
MT001
Keywords
Life sciences park, university-hospital-industry technology transfer, biotech incubation

Context

Malta Life Sciences Park (MLSP), in San Ġwann, was conceived by Malta Enterprise — Malta's national economic development agency — to give life-sciences and IT companies a state-of-the-art site alongside the country's main research and clinical institutions.

Objectives

To let companies commercialise research with minimal set-up time, leveraging direct proximity to the University of Malta, Mater Dei Hospital and Malta's Oncology Hospital; the project targeted more than 500 jobs by 2019.

Activities

The BioMalta campus provides 13,500 m² of laboratories, offices, seminar and meeting space across four buildings, including 61 lab units of which 11 are dedicated incubation units.

Results

Confirmed tenants include backup-software company Altaro, pharmaceutical firm Alvogen, and diagnostics/lab-services firms BioDNA Laboratory Services and Bioscint Engineering, among others on the park's current tenant directory.

Conclusions

The original 500-jobs-by-2019 target is a forward projection from the park's launch, not a verified outcome; no source reviewed confirms whether it was met, and no independent count of total current jobs or spin-out companies from University of Malta/Mater Dei research was found.

Implementation
Indicative cost
High (€500k–€5M) — 13,500 m² purpose-built BioMalta campus across four buildings with 61 lab units (11 incubation units) implies a substantial national capital investment; no explicit budget figure found in sources.
Time to results
Medium (1–3 years) — Operating since 2016 (about 10 years).
Staffing & skills
Malta Enterprise (national economic development agency), University of Malta, Mater Dei Hospital, Malta's Oncology Hospital

Conditions for success

  • Direct proximity to University of Malta, Mater Dei Hospital and Oncology Hospital
  • Minimal set-up time enabling companies to commercialise research quickly

Common failure modes

  • 500-jobs-by-2019 target is an unverified forward projection, not a confirmed outcome
  • No independent count of total jobs or spin-out companies from university/hospital research was found

Commonly funded by

National / regional programmes ERDF — European Regional Development Fund

Indicative funding routes for practices of this type — always check each programme's current calls and eligibility rules.

Do you run this practice? Claim it — verified implementers get a public contact pathway and can propose corrections.

Data sources

Where this practice's information was retrieved from, and when.

Attachments

Similar practices you may find useful